Cellectis (CLLS) FCF Margin (2015 - 2026)
Cellectis (CLLS) posted quarterly FCF Margin of 262.16% for Q1 2026, down 10482.0% year-over-year from N/an in Q1 2025, and down 128.32% quarter-over-quarter from 114.82% in Q4 2025.
Powered by 
Analysis
Cellectis (CLLS) FCF Margin (2015 - 2026) Analysis & Trends
Cellectis' FCF Margin history runs 12 years deep, the most recent figure standing at 262.16% for Q1 2026.
- In Q1 2026, FCF Margin fell 10482.0% year-over-year to 262.16%; the TTM figure through Mar 2026 stood at 57.03% (down 10534.0% YoY), while the FY2025 annual figure was 57.25%, down 9871.0% from the prior year.
- FCF Margin for Q1 2026 stood at 262.16%, down from 114.82% in the prior quarter.
- The five-year high for FCF Margin was 660.19% in Q2 2024, with the low at 20225.18% in Q1 2023.
- The 5-year median for FCF Margin is 157.34% (2025), against an average of 3542.25%.
- The sharpest annual moves came in 2023 and 2024: FCF Margin plunged 1806386 bps in 2023, then surged 1971509 bps in 2024.
- Cellectis' FCF Margin stood at 35.2% in 2022, then soared by 1333 bps to 433.98% in 2023, then plunged by 105 bps to 22.83% in 2024, then tumbled by 403 bps to 114.82% in 2025, then sank by 128 bps to 262.16% in 2026.
- Business Quant data shows CLLS's FCF Margin at 262.16% in Q1 2026, 114.82% in Q4 2025, and 1.11% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - | -268.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -268.33% |
| Mar 31, 2026 | -262.16% |
| Dec 31, 2025 | -77.71% |
| Sep 30, 2025 | -1.11% |
| Jun 30, 2025 | -59.82% |
| Mar 31, 2025 | -157.34% |
| Dec 31, 2024 | 3.96% |
| Sep 30, 2024 | -15.68% |
| Jun 30, 2024 | 629.03% |
| Mar 31, 2024 | -510.09% |
| Dec 31, 2023 | 14,131.80% |
| Sep 30, 2023 | -10,202.58% |
| Jun 30, 2023 | -11,089.33% |
| Mar 31, 2023 | -20,225.18% |
| Dec 31, 2022 | -4.86% |
| Sep 30, 2022 | -12,864.57% |
| Jun 30, 2022 | -1,969.09% |
| Mar 31, 2022 | -2,161.32% |
| Dec 31, 2021 | -202.62% |
| Sep 30, 2021 | 17.67% |